Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
The Food and Drug Administration recently approved KVK Tech's drug Lomaira.
Thirteen top drug companies joined efforts to fight antimicrobial resistance by vowing to reduce pollution emitted from antibiotic factories, according to a statement released on Tuesday.
Emma Walmsley will replace Andrew Witty as CEO of Britain-based GlaxoSmithKline when he retires on March 31, making her the first women to manage a leading global drug company, according to Reuters.
West Virginia Attorney General Patrick Morrisey (R) launched an investigation on Mylan over potential antitrust violations and state Medicaid fraud, reported USA Today.
Blackstone, a private equity company based in New York City, will purchase Irvine, Calif.-based LBA Realty's portfolio of logistics centers for $1.5 billion, according to The Wall Street Journal.
Cambridge, Mass.-based Sarepta Therapeutics earned tentative approval from the Food and Drug Administration for its Duchenne's muscular dystrophy drug eteplirsen, according to The New York Times.
A recent report from the Government Accountability Office found that while Medicare Part D generic drug prices decreased overall from 2010 to 2015, many showed exorbitant price hikes.
Joe Kaeser, CEO of Germany-based Siemens, believes geopolitical turbulence may prevent customers from spending money on projects, limiting the amount of orders and revenue the engineering company brings in, reported Bloomberg.
Abbott Laboratories will divest its eye care division to Johnson & Johnson for about $4.33 billion in cash, reported Reuters.
Jimmy Kimmel cracked a joke during the 2016 Emmy Awards about a topic few are smiling about: high drug prices.